Scientists have known for more than 10 years that a certain extract from leaves of the ancient eastern tree, Ginkgo biloba, can somewhat ease symptoms of memory loss in Alzheimer’s disease patients.
Now, researchers at the University of Maryland School of Pharmacy are learning how the popular extract actually works in Alzheimer’s patients.
Understanding the biochemical workings of the ginkgo extract could help doctors expand treatment options for other medical conditions. A synergy, or the combination of separate actions by the Ginkgo extract, common in herbal remedies, may be the key to its effectiveness, says Yuan Luo, PhD, associate professor at the School of Pharmacy.
In ongoing studies, a research team led by Luo found that giving mice with the human Alzheimer’s gene the ginkgo extract called Egb 761 improved the process of making new nerve cells in part of the brain much affected by the disease. The team found evidence that the protective effect of the extract also could be due to decreasing senile plaques or the clumping of beta-amyloid in the brain tissues. Amyloid is part of a protein and a central factor in the progression of Alzheimer’s disease.
Currently Alzheimer’s disease is causing progressive dementia and sometimes death in about four million Americans, mostly people older than 70. In the U.S., the incidence of Alzheimer’s disease has steadily increased as the average life span has lengthened. Currently, there are no drugs with disease-modifying or preventive properties. However, the School of Pharmacy study and others are now suggesting that many of the symptoms can be avoided or significantly reduced.
The disease starts with loss of nerve connections and broken circuitry of nerve signals in synapses. Modern neuropathology studies beginning in the 1960’s revealed that adults create new nerve cells continually in learning regions of the brain. One of the regions of neurogenesis is in the hippocampus, important to memory and cognition. Luo’s study demonstrated the dual effect of Ginkgo extract in the hippocampus—enhanced making of nerve cells and decreased clumping in brain tissue.
“By finding out how it works, it might help drug discovery researchers and doctors learn how other herbal and conventional drugs work on in multiple ways,” said Luo. When herbal medicines are effective, she said, it’s often because of a synergy of different biological effects. “Alzheimer’s disease is caused by multiple factors, not just one thing that has gone wrong.” Therefore, drugs that target multiple sites would be most efficacious, she added.
Results from the School of Pharmacy experiments, slated to continue for at least another year, provide a rationale for future medicinal chemistry and for identifying other potentially efficacious compounds with desirable activity as potential therapeutic agents to prevent and/or treat Alzheimer’s disease, according to Luo.
Meanwhile, to confirm or refute the theory that medicine made from Ginkgo biloba can prevent or delay changes in memory, thinking, and personality as people get older, researchers are currently analyzing data from a five-year clinical trial, The Ginkgo Evaluation of Memory, sponsored by the National Institutes of Health. About 3,000 people at four clinics, including one in Hagerstown, Md., participated.
Luo’s research team is focused on aging, age-related neurodegenerative diseases, and neuroprotective mechanisms. While disease prevention theories associated with herbal medicine have the potential to both increase quality of life and reduce health care costs, ways that extracts of herbs work in the body are still poorly understood, she says.
Steve Berberich | Newswise Science News
What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Materials Sciences
06.12.2016 | Medical Engineering
06.12.2016 | Power and Electrical Engineering